Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome

Abstract

In the intent-to-treat population of patients with ARDS, treatment with liposomal prostaglandin E1 accelerated improvement in indexes of oxygenation but did not decrease the duration of mechanical ventilation and did not improve day 28 survival.